TOMI Environmental Solutions, Inc.

Good afternoon. Welcome to the TOME Environmental Solutions Third Quarter 2021 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions and comments following the presentation. It is now my pleasure to turn the floor over to your host, John Nesbitt of IMS Investor Relations. Sir, the floor is yours.

Thank you for joining us today for the TOME Environmental Solutions Investor Update Conference Call. On today's call is Tomi's Chief Executive Officer and Chairman, Dr. Halden Shane, and Nick Jennings, Tomi's Chief Financial Officer. Dr. Shane will provide an overview of recent business highlights and discuss critical financial benchmarks for the most recent quarter before addressing any questions you may have. A telephone replay of today's calls will be available through November 26, 2021, the details of which are included in the company's press release issued this morning. A webcast will also be available at Tomi's website, www.tomimist.com. We remind you that during this conference call, we will make certain forward-looking statements, including discussions of the business outlook and financial projections. These forward-looking statements are based on management's current expectations and involve risks and uncertainties that could cause the actual results to differ materially from such expectations. For a more detailed description of these risks and uncertainties, please refer to our recent and subsequent filings with the SEC. We assume no obligation to update the information provided in today's call. We also note that during this call, we'll be discussing certain non-GAAP financial information because we believe they provide useful information about our operating performance that should be considered by investors together with the GAAP measures that we provide. A reconciliation of these non-GAAP measures to comparable gap measures is included in the earnings release. I will now give the call to TOME's Chief Executive Officer and Chairman, Dr. Alden Shain. Go ahead, Alden.

Thank you, and welcome to TOME Environmental Solutions' third quarter 2021 earning call. We appreciate you taking time away from your schedule to join us this afternoon, and I apologize for the timing of the call on a Friday. as the company is involved in a very important trade show on Monday, which requires my attendance. The third quarter saw a strong 50% sequential growth from the second quarter. The launch of an exciting new product that is being well received, the opening of a brand new direct-to-consumer distribution channel through Amazon, and significant progress improving logistics and quality control. As we move into the post-pandemic world, a focus on the growth and market opportunities during 2021, we continue to partner with premier quality customers that expand the use of our technology. Our reputation as a leading decontamination solution is validated by many referrals we receive from our existing customers. Pfizer and Merck are on track to become Tomy's top expansion customers, to name a few. LabCorp, Icahn School of Medicine, Mount Sinai, St. Jude Children's Research Hospital, and the Department of Homeland Security's National Lab at Plum Island Animal Disease Center. All are nice additions to our premier customer list. These new customers, along with our long-term customers, partnerships around the world should enable us to continue to obtain referrals to our Sturimus brand. For Sturimus to become the standard in its industry, it's important for us to continue educating the world on quick, non-caustic, environmentally friendly, proper disinfection and decontamination protocols and procedures, and validation from our customer base along with their referrals, are critical to achieving our market position and growth. We believe that our long-term orientated partnership will boost revenue and growth across all our company divisions. We are excited about the launch of the Steripak, our new all-in-one design which brings the power of Sterimist onto your back, weighing approximately 17 pounds. It utilizes a rechargeable battery and a new compact bit solution bottle. The product easily switches between battery and direct power, perfect for maneuvering through all indoor areas. Our initial trials are receiving positive remarks. Another product, the Select Plus, is in the final design phase with a rollout expected by the end of the year. This is a hybrid product consisting of the company's current Surface Select and environment systems. This unit will allow for enhanced flexibility by using a single rotating applicator to decontaminate full room to small space volume with more robust process controls. In addition, this product will be smaller and lighter than its current select model. We developed this product line in collaboration with Catalan, who will validate our new unit this month Our partnership with Catalan has resulted in three Catalan facilities processing our purchase orders for approval within their procurement. Transport, a custom engineered system, or CES, has been designed for transportation market, specifically for the paramedical vehicles and transport ambulances. Transport CES is a time-based fogging system that can be installed semi-permanently or permanently and used for any transport and or cargo vehicle. It will be a key-to-use turnkey integration system. We believe that the implementation of this product and our patented non-corrosive IHP technology will eventually replace the number one competitor in this marketplace. which uses an extremely harsh caustic chemical. The Transport CES already has potential large-size sale pending with one of TOMI's current hospital system customers and has been forecasted in their 2022 budget. The TOMI original models have the option of software updates. We are working with existing customers to upgrade their existing products. As many Industrial companies are reducing R&D and capital expenditures due to the economic impact of the pandemic. TOME continues its capital and operating expenditures. At the moment, our supply chain continues to be managed, and we have ordered our long lead item parts that are required for our building materials in advance, as we expected supply chain congestion and shortages. This will allow us to continue to manufacture our products to meet customer demands. We are experiencing an increase in costs in parts and shipping, which will be reflected in pricing. Further, we hope any risk of supply chain constraint is mitigated by the fact that we have multiple suppliers, outsourced engineers, and software programmers to turn to for the manufacturing installation of our Sturimus products. Long-term ongoing projects and proposals for our permanent custom engineered system decontamination room continue to progress through the user requirement specification stages with many customer facilities. We expect these installations to have a positive impact on our results in 2022 and 23 and thereafter. As released earlier this quarter, Tomy Sterimist won a bid for our IHP CES from a major pharmaceutical company in Europe. The Tomy tech team successfully completed the factory acceptance test, or as known in the industry, the FAT test, on the system last week and is ahead of schedule for delivery and installation. This system will meet the European CGMP requirements, and is anticipated to be TOME's most intelligent system to date with advanced software programming required for operation. We continue to expand the range of bit solution options for our CES system. The latest design CES is being offered with a five-gallon container of bit solution. All our bit solution options remain RFID protected in usage. We are better positioned than ever to meet the needs of our customers going forward, and we expect a strong end to the fiscal year and certainly in 2022 and beyond. Before I continue with operation updates and my closing remarks, let me first turn the call over to Nick Jennings, our CFO, for a review of our financial results.